Nutri Financial Statements From 2010 to 2026
| NRPR Stock | USD 0.05 0.00 0.00% |
Check Nutri Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutri Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Nutri financial statements analysis is a perfect complement when working with Nutri Pharmaceuticals Valuation or Volatility modules.
Nutri |
Nutri Pharmaceuticals Research Company Profit Margin Analysis
Nutri Pharmaceuticals' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Nutri Pharmaceuticals Profit Margin | (0.39) % |
Most of Nutri Pharmaceuticals' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutri Pharmaceuticals Research is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Nutri Pharmaceuticals Research has a Profit Margin of -0.3861%. This is 96.56% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 69.6% lower than that of the firm.
Nutri Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nutri Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Nutri Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutri Pharmaceuticals competition to find correlations between indicators driving Nutri Pharmaceuticals's intrinsic value. More Info.Nutri Pharmaceuticals Research is regarded third in profit margin category among its peers. It is regarded fifth in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nutri Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About Nutri Pharmaceuticals Financial Statements
Nutri Pharmaceuticals shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Nutri Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Nutri Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Nutri Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Nutri Pharmaceuticals Research, Inc. engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. The company uses its oil to powder products as ingredients in finished goods, such as food, pet food, nutraceuticals or vitamin supplements, cosmetics, and organic household products. Nutri Pharms operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Pair Trading with Nutri Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nutri Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nutri Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Nutri Pink Sheet
| 0.91 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.78 | TKPHF | Takeda Pharmaceutical | PairCorr |
| 0.75 | HLN | Haleon plc | PairCorr |
Moving against Nutri Pink Sheet
The ability to find closely correlated positions to Nutri Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nutri Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nutri Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nutri Pharmaceuticals Research to buy it.
The correlation of Nutri Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nutri Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nutri Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nutri Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Nutri Pink Sheet Analysis
When running Nutri Pharmaceuticals' price analysis, check to measure Nutri Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutri Pharmaceuticals is operating at the current time. Most of Nutri Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nutri Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutri Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nutri Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.